Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 6;5(3):1685-1691.
doi: 10.1021/cs5018612. Epub 2015 Jan 29.

Enzymatic C(sp3)-H Amination: P450-Catalyzed Conversion of Carbonazidates into Oxazolidinones

Affiliations

Enzymatic C(sp3)-H Amination: P450-Catalyzed Conversion of Carbonazidates into Oxazolidinones

Ritesh Singh et al. ACS Catal. .

Abstract

Cytochrome P450 enzymes can effectively promote the activation and cyclization of carbonazidate substrates to yield oxazolidinones via an intramolecular nitrene C-H insertion reaction. Investigation of the substrate scope shows that while benzylic/allylic C-H bonds are most readily aminated by these biocatalysts, stronger, secondary C-H bonds are also accessible to functionalization. Leveraging this "non-native" reactivity and assisted by fingerprint-based predictions, improved active-site variants of the bacterial P450 CYP102A1 could be identified to mediate the aminofunctionalization of two terpene natural products with high regio- and stereoselectivity. Mechanistic studies and KIE experiments show that the C-H activation step in these reactions is rate-limiting and proceeds in a stepwise manner, namely, via hydrogen atom abstraction followed by radical recombination. This study expands the reactivity scope of P450-based catalysts in the context of nitrene transfer transformations and provides first-time insights into the mechanism of P450-catalyzed C-H amination reactions.

Keywords: C−H amination; biocatalysis; carbonazidate; cytochrome P450; oxazolidinones.

PubMed Disclaimer

Figures

Figure 1
Figure 1
P450-catalyzed C–H amination in terpene natural products. The graphs illustrates the relative activity, based on TON, for the FL#62-derived active-site variants selected by fingerprint analysis (SCA). The amino acid mutations in the P450 variants can be found in Table S1. “s.r.c.” = standard reaction conditions, as indicated in Table 2.
Figure 2
Figure 2
Proposed mechanism for P450-catalyzed conversion of carbonazidates to oxazolidinones. The competing pathway leading to the carbamate byproduct is indicated in blue. Y = —OC(O)—.
Figure 3
Figure 3
Rearrangement studies. (a) FL#62-catalyzed cyclization of (E)-12 (or its isomer (Z)-12) leads to formation of trans oxazolidinone (E)-21, as determined by HPLC (Figure S3 in SI) and GC-MS analysis. The ZE rearrangement in case of (Z)-12 is indicative of the formation radical intermediate via HAA. (b) Rhodium-catalyzed cyclization of carbamate Z-27 is not accompanied by scrambling of the double bond configuration, in agreement with the concerted nitrene C–H insertion mechanism proposed for these catalysts.
Figure 4
Figure 4
Kinetic isotope effect (KIE) experiments. (a) KIE value for FL#62-catalyzed amination of 6 and its deuterated analogue, D-6. The graph reports a plot of initial rate versus substrate concentration for the two reactions. (b) Comparison of KIEintra and KIEinter values as determined from intramolecular (D1-11) and intermolecular (1:1 mixture of 11 and D2-11) competition experiments, followed by GC-MS analysis (Figure S5).

References

    1. Wilson M. E.; Whitesides G. M. J. Am. Chem. Soc. 1978, 100, 306–307 10.1021/ja00469a064. - DOI
    1. Collot J.; Gradinaru J.; Humbert N.; Skander M.; Zocchi A.; Ward T. R. J. Am. Chem. Soc. 2003, 125, 9030–9031 10.1021/ja035545i. - DOI - PubMed
    1. Reetz M. T.; Peyralans J. J. P.; Maichele A.; Fu Y.; Maywald M. Chem. Commun. 2006, 4318–4320 10.1039/b610461d. - DOI - PubMed
    1. Abe S.; Niemeyer J.; Abe M.; Takezawa Y.; Ueno T.; Hikage T.; Erker G.; Watanabe Y. J. Am. Chem. Soc. 2008, 130, 10512–10514 10.1021/ja802463a. - DOI - PubMed
    1. Mayer C.; Gillingham D. G.; Ward T. R.; Hilvert D. Chem. Commun. 2011, 47, 12068–12070 10.1039/c1cc15005g. - DOI - PubMed

LinkOut - more resources